Published in Br J Cancer on December 05, 2013
Regression analysis of combined gene expression regulation in acute myeloid leukemia. PLoS Comput Biol (2014) 0.94
Network-based survival-associated module biomarker and its crosstalk with cell death genes in ovarian cancer. Sci Rep (2015) 0.87
MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells. Biochim Biophys Acta (2014) 0.77
Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries. J Steroid Biochem Mol Biol (2016) 0.77
Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties. J Cancer Res Clin Oncol (2015) 0.77
Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer. PLoS One (2015) 0.76
Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function. Mol Clin Oncol (2015) 0.75
The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection. BMC Microbiol (2017) 0.75
Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate. Proc Natl Acad Sci U S A (2017) 0.75
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer. J Ovarian Res (2017) 0.75
Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture. PLoS One (2016) 0.75
mRNA expression profile of mouse oligodendrocytes in inflammatory conditions. Dokl Biochem Biophys (2016) 0.75
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta (1991) 11.78
Guidelines for the welfare and use of animals in cancer research. Br J Cancer (2010) 6.97
T-cell function and migration. Two sides of the same coin. N Engl J Med (2000) 6.47
AP-1 in cell proliferation and survival. Oncogene (2001) 6.07
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell (1984) 5.55
The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer (2005) 2.63
Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J (1989) 2.37
Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol (1998) 2.22
Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol (2006) 2.06
Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov (2011) 1.88
Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets (2007) 1.82
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene (2005) 1.80
Fos-transformation activates genes associated with invasion. Oncogene (1994) 1.66
c-fos expression induces bone tumors in transgenic mice. Oncogene (1989) 1.40
C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology (1998) 1.33
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol (2006) 1.24
Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res (2008) 1.19
Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal (2008) 1.16
The transcription factor Fos: a Janus-type regulator in health and disease. Histol Histopathol (2009) 1.14
c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J Biol Chem (2004) 1.09
c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells. Cancer Res (2007) 1.09
C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer (2008) 1.08
The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene (2003) 1.08
Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer (2007) 1.02
Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and mice. PLoS One (2010) 1.00
TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis (2004) 0.97
Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression. Clin Cancer Res (2012) 0.97
Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin Cancer Res (2002) 0.97
Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. J Clin Invest (2012) 0.95
Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett (2000) 0.94
Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation. Blood (2004) 0.91
Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathol Oncol Res (2007) 0.90
c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells. Mol Carcinog (2006) 0.90
Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. Cell Death Differ (2004) 0.89
Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. J Mol Endocrinol (2003) 0.89
Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice. Gut (2012) 0.87
The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells. Eur J Cancer (2010) 0.86
Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation. Histochem Cell Biol (2011) 0.86
The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J Atheroscler Thromb (2000) 0.86
Milky spots in the human greater omentum. Macroscopic and histological identification. Acta Anat (Basel) (1989) 0.85
Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer. Cancer Lett (2012) 0.85
Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells. J Cancer Res Clin Oncol (2012) 0.85
Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Exp Cell Res (2006) 0.84
Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines. Oncol Rep (2009) 0.83
Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis. Int J Mol Med (2010) 0.82
Screening of specific changes in mRNAs in thyroid tumors by sequence specific differential display: decreased expression of c-fos mRNA in papillary carcinoma. Endocr J (1999) 0.81
Microglia use multiple mechanisms to mediate interactions with vitronectin; non-essential roles for the highly-expressed αvβ3 and αvβ5 integrins. J Neuroinflammation (2011) 0.80
The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature. Cancer Lett (2012) 0.79
Effect of c-fos antisense probe on prostaglandin E2-induced upregulation of vascular endothelial growth factor mRNA in human liver cancer cells. World J Gastroenterol (2005) 0.77